ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

Three Experimental Beamlines To Be Built For Research.

May 17, 2002

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

September 20, 1991

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014

New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports

July 26, 2002

In Brief: House Hearings On NIH Budget Begin Feb. 1; Army Program Is Peer Reviewing Proposals

January 28, 1994

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001